Daratumumab, Lenalidomide, and Dexamethasone (DRD), an Active Regimen in the Treatment of Sirolimus-Associated Plasmablastic Lymphoma (PBL) in the Setting of Gorham's Lymphangiomatosis: A Case Report Lee, M., Martin, B., Abdulhaq, H. CIG MEDIA GROUP, LP. 2020: S275

View details for Web of Science ID 000564055100270